(Alliance News) - Solvonis Therapeutics PLC said on Wednesday that it will be focusing on funding its research projects, after reporting no sources of revenue for its latest year. Read More
(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Friday and not separately reported by Alliance News: Read More
(Alliance News) - Solvonis Therapeutics PLC on Wednesday reported "positive progress" on its European patent application for the Awkn-Sdn-14 programme. Read More
(Alliance News) - Solvonis Therapeutics PLC on Monday said it entered into an arrangement agreement to buy Toronto-based Awakn Life Sciences Corp. Read More
